Synchrotron X-ray imaging reveals a correlation of tumor copper speciation with Clioquinol's anticancer activity
Tumor development and metastasis depend on angiogenesis that requires certain growth factors, proteases, and the trace element copper (Cu). Recent studies suggest that Cu could be used as a novel target for cancer therapies. Clioquinol (CQ), an antibiotic that is able to form stable complexes with Cu or zinc (Zn), has shown proteasome-inhibitory, androgen receptor-suppressing, apoptosis-inducing, and antitumor activities in human cancer cells and xenografts. The mechanisms underlying the interaction of CQ with cellular Cu, the alteration of the Cu/Zn ratio and the antitumor role of CQ in vivo have not been fully elucidated. We report here that Cu accumulates in tumor tissue and that the Cu/Zn balances in tumor, but not normal, tissue change significantly after the treatment with CQ. Cu speciation analysis showed that the Cu(I) species is predominant in both normal and tumor tissues and that Cu(II) content was significantly increased in tumor, but not normal tissue after CQ treatment. Our findings indicate that CQ can interact with cellular Cu in vivo, dysregulates the Cu/Zn balance and is able to convert Cu(I) to Cu(II) in tumor tissue. This conversion of Cu(I) to Cu(II) may be associated with CQ-induced proteasome inhibition and growth suppression in the human prostate tumor xenografts.
- Research Organization:
- Argonne National Laboratory (ANL)
- Sponsoring Organization:
- USDOE
- OSTI ID:
- 1005917
- Journal Information:
- J. Cell. Biochem., Journal Name: J. Cell. Biochem. Journal Issue: (1) ; 09, 2009 Vol. 108; ISSN JCEBD5; ISSN 0730-2312
- Country of Publication:
- United States
- Language:
- ENGLISH
Similar Records
1-o-acetylbritannilactone (ABL) inhibits angiogenesis and lung cancer cell growth through regulating VEGF-Src-FAK signaling
A binuclear complex constituted by diethyldithiocarbamate and copper(I) functions as a proteasome activity inhibitor in pancreatic cancer cultures and xenografts
Augmentation of radiation response with the vascular targeting agent ZD6126
Journal Article
·
Fri Aug 21 00:00:00 EDT 2015
· Biochemical and Biophysical Research Communications
·
OSTI ID:22462197
A binuclear complex constituted by diethyldithiocarbamate and copper(I) functions as a proteasome activity inhibitor in pancreatic cancer cultures and xenografts
Journal Article
·
Sat Dec 14 23:00:00 EST 2013
· Toxicology and Applied Pharmacology
·
OSTI ID:22285527
Augmentation of radiation response with the vascular targeting agent ZD6126
Journal Article
·
Fri Mar 31 23:00:00 EST 2006
· International Journal of Radiation Oncology, Biology and Physics
·
OSTI ID:20793432